Mycobacterium bovis-BCG Vaccination Induces Specific Pulmonary Transcriptome Biosignatures in Mice-Reference-Cited by-同舟云学术

Mycobacterium bovis-BCG Vaccination Induces Specific Pulmonary Transcriptome Biosignatures in Mice

Published:2010-06-28 Issue:6 Volume:5 Page:e11319
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Aranday Cortes Elihu,Kaveh Daryan,Nunez-Garcia Javier,Hogarth Philip J.,Vordermeier H. Martin

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle.;HM Vordermeier;Vet J,2006

2. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.;SA Armstrong;Nat Genet,2002

3. Genomic and molecular profiling predicts response to temozolomide in melanoma.;CK Augustine;Clin Cancer Res,2009

4. Immune Response to Mycobacterium tuberculosis and Identification of Molecular Markers of Disease.;M Gonzalez-Juarrero;Am J Respir Cell Mol Biol,2008

5. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.;D Gaucher;J Exp Med,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent;2024-06-21

2. Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains;Tuberculosis;2024-05

3. Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice;PLOS ONE;2023-08-03

4. A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19;Frontiers in Immunology;2022-08-26

5. Recent developments in systems biology and genetic engineering toward design of vaccines for TB;CRIT REV BIOTECHNOL;2022